Study drug vs usual treatment for brief trouble sleeping
Part of Brain & nervous system, Mental health clinical trials.
This Phase 2 study tests whether an investigational sleep medicine (SM-1) can improve short-term trouble falling asleep or staying asleep. It compares the study drug against an active, already-used sleep treatment in people who are not currently having ongoing insomnia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 25 and 55 years old
- Your body weight (BMI) must be between 19 and 32
- You usually go to bed between 9:00 pm and midnight, and your sleep schedule stays fairly consistent
- In the past you’ve had occasional trouble sleeping, but you are not currently having major sleep problems
- You must be generally healthy, and agree to sign consent and stay overnight in the research unit for each treatment period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a behavioral (non-medication) program to help people with chronic insomnia sleep better. It may help if you regularly use sleep medications but still struggle with staying asleep or falling asleep.
This trial tests a new medication, APSTZD, to see how well it works and how safe it is for people with insomnia, especially those who have trouble staying asleep through the night.
This trial studies whether timed light exposure can help people who have trouble falling asleep. It aims to improve insomnia symptoms by testing a light-based approach while carefully measuring sleep patterns.
This study tests if adding a short behavioral therapy program helps people with chronic insomnia who are already taking sleep medication. It looks at whether this combination improves sleep and is cost-effective.
This trial tests whether a part of the brain called the locus coeruleus is involved in insomnia. It involves sleep questionnaires and possibly brain imaging to understand your sleep problems better.
This study tests if the drug tasimelteon helps children with insomnia sleep better compared to a placebo (a pill with no medicine). It is for children aged 2 to 17 who have been diagnosed with insomnia that is not caused by another medicine.
Hear when a new Transient Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.